MOTS-C vs Tirzepatide for blood sugar
Short answer: For blood sugar, more users report improvement with Tirzepatide — 80% of 10 reports, versus 40% of 5 for MOTS-C.
MOTS-C has 0 meta-analyses and 4 randomized trials on PubMed; Tirzepatide has 214 and 132.
Based on 203 reports about MOTS-C and 408 about Tirzepatide. Not medical advice.
| MOTS-C Peptide | Tirzepatide Medication | |
|---|---|---|
| User score | 50 | 68 |
| Verdict | Mixed | Mostly positive |
| Positive of reports that state an outcome | 49% | 76% |
| Reports | 203 | 408 |
| Research | CResearch: Limited | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 4 | 214 / 132 |
| Mainly used for | ||
| Weight loss % reporting improvement | 85% (13) | 93% (195) |
| Appetite % reporting improvement | — | 86% (71) |
| Focus % reporting improvement | 83% (6) | 67% (3) |
| Energy % reporting improvement | 84% (74) | 45% (31) |
| Sleep % reporting improvement | 0% (5) | 56% (9) |
| Mood % reporting improvement | 100% (5) | 68% (25) |
| Performance % reporting improvement | 85% (34) | 83% (12) |
| Pain & inflammation % reporting improvement | — | 86% (7) |
| Digestion % reporting improvement | — | 20% (5) |
| Libido % reporting improvement | — | 33% (6) |
| Hormones % reporting improvement | — | 50% (2) |
| Blood sugar % reporting improvement | 40% (5) | 80% (10) |
| Heart & lipids % reporting improvement | — | 88% (8) |
| Skin & hair % reporting improvement | — | 0% (2) |
| Immunity % reporting improvement | 50% (2) | — |
| Common side effects | fatigue, insomnia, injection site, dizziness | fatigue, nausea, constipation, stomach issues |
| Typical dose reported | Not listed | 7.5 mg |
MOTS-CFull MOTS-C profile →
What a user said
“Taking these makes me feel wildly energetic all day—zero afternoon slumps, and my endurance during cardio feels bottomless.”
TirzepatideFull Tirzepatide profile →
Latest review conclusion
This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Pharmacol Res, 2021 ↗What a user said
“Tirzepatide works so well! Do some research in the r/peptides subreddit and the r/tirzepatide subreddit. It's the most effective thing I've ever seen for appetite suppressant.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate